# $glmd

Galmed Pharmaceuticals ($GLMD) sees a surge in social media buzz, with X (formerly Twitter) dominating discussions. Recent posts highlight a potential billion-dollar drug and a strong balance sheet, though concerns linger about the stock price relative to its share price.

### About $glmd
Galmed Pharmaceuticals is a biopharmaceutical company.  

### Engagements: [-----] (24h)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$glmd/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/$glmd/time-series/interactions.tsv)  
Current Value: [-----]  
Daily Average: [-----]  
[--] Week: [---] -78%  
[--] Month: [------] -14%  
[--] Months: [---------] -39%  
[--] Year: [---------] -38%  
1-Year High: [-------] on 2025-11-17  
1-Year Low: [--] on 2025-09-28  

Engagements by network (24h):
Reddit: [--]
X: [-----]
TikTok: [--]
YouTube: [--]

  
  
### Mentions: [--] (24h)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$glmd/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/$glmd/time-series/posts_active.tsv)  
Current Value: [--]  
Daily Average: [--]  
1-Year High: [---] on 2025-11-17  
1-Year Low: [--] on 2025-09-23  

Mentions by network (24h):
Reddit: [--]
X: [--]
TikTok: [--]
YouTube: [--]

  
  
### Creators: [--] (24h)
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$glmd/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/$glmd/time-series/contributors_active.tsv)  
[--] unique social accounts have posts mentioning $glmd in the last [--] hours which is up 67% from [--] in the previous [--] hours
Daily Average: [--]  
1-Year High: [---] on 2025-11-17  
1-Year Low: [--] on 2025-09-23  

The most influential creators that mention $glmd in the last [--] hours

| Creator                                              | Rank | Followers | Posts | Engagements |
| -------                                              | ---- | --------- | ----- | ----------- |
| [@ej23ny](/creator/twitter/ej23ny)                   | [--]    | [-----]     | [--]     | [-----]       |
| [@mariostario2019](/creator/twitter/mariostario2019) | [--]    | [--]        | [--]     | [---]         |
| [@TradesProfits](/creator/twitter/TradesProfits)     | [--]    | [---]       | [--]     | [--]          |
| [@BuyTheUgly](/creator/twitter/BuyTheUgly)           | [--]    | [--]        | [--]     | [--]          |
| [@ib24059210](/creator/twitter/ib24059210)           | [--]    | [--]        | [--]     | [--]          |

[View More](/list/creators/$glmd/100)
  
  
### Sentiment: 100%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$glmd/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$glmd/time-series/sentiment.tsv)  
Current Value: 100%  
Daily Average: 88%  
[--] Week: 100% no change  
[--] Month: 100% no change  
[--] Months: 100% +25%  
[--] Year: 100% no change  
1-Year High: 100% on 2025-02-13  
1-Year Low: 29% on 2025-08-11  

Most Supportive Themes:
- Strong Balance Sheet and No Debt: (30%) The company's financial health is highlighted by its substantial cash reserves and lack of debt, making it an attractive investment.
- Potential Billion Dollar Drug: (25%) The company is developing a drug with the potential for significant market success, indicating future growth prospects.
  
Most Critical Themes:
- Stock Price vs. Share Price: (45%) The current stock price is significantly lower than the price at which shares were previously sold, raising concerns about investor returns.
  

### Top $glmd Social Posts
Top posts by engagements in the last [--] hours

*Showing a maximum of [--] top social posts without a LunarCrush subscription.*

"$SPY $QQQ $TSLA $TNXP %0.80 $NVDA $AMD $DJT $AMC $GME $SMCI $SQQQ $IWM $FRGT $GLMD $WHLR $PLTR $BTC %1.68 $DIA $ORCL $AAPL $GOOGL $META %5.13 $AMZN $GLMD %0.23 $AMD $OMEX $VVOS $XCUR $INTC $SMCI $MARA %5.23 $SHOT $FCUV $EJH $SMC $SGN $MYND $BURU MSTR https://strategycore.pro/01 https://strategycore.pro/01"  
[X Link](https://x.com/HiKARUD_FXXK/status/2021049984624251378) [@HiKARUD_FXXK](/creator/x/HiKARUD_FXXK) 2026-02-10T02:34Z [---] followers, [---] engagements


"My favorite low float stocks $GLMD big position on my portfolio [---] to 11M OS $HIND 6M OS $QTTB [----] OS $XBI $IBB Low float $GLMD -4% I expect reversal $HIND +22% $XBI $IBB Low float $GLMD -4% I expect reversal $HIND +22% $XBI $IBB"  
[X Link](https://x.com/ej23ny/status/2020956363405361357) [@ej23ny](/creator/x/ej23ny) 2026-02-09T20:21Z [----] followers, [----] engagements


"$GLMD abstract published of lead asset Aramchol. Results looking promising Next step the company and sponsor is designing phase [--] trial $KULR $SAFX $SRXH $SCNX $MTEN $IVP $RIME $IBRX $JTAI $GSIT $XBI $RARE $VKTX $ADTX $HIND https://x.com/oncotarget/status/2002091681785462940s=46 🎥 #OncotargetShort: Abstract #video about this #research paper #published in Vol. [--] titled "The SCD1 inhibitor aramchol interacts with regorafenib to kill GI tumor cells in vitro and in vivo." @VCU 🔗 https://t.co/nNfAzMdKjL #cancer #TrendingWithImpact #tumors #oncology #oa https://t.co/8pOfoKuifh"  
[X Link](https://x.com/ej23ny/status/2020947973060915451) [@ej23ny](/creator/x/ej23ny) 2026-02-09T19:48Z [----] followers, [---] engagements


"$GLMD IMHO extremely high rewards at this level and low risk. Cash in hand is at least $2 yahoo has $3.49 per share $KULR $SAFX $SRXH $SCNX $MTEN $IVP $RIME $IBRX $JTAI $GSIT $XBI $RARE $VKTX $ADTX $HIND $GLMD loaded up last couple of days: Yahoo Finance Financial Highlights of $Glmd Total Cash $19M Book Value Per Share $3.49 $KULR $SAFX $SRXH $SCNX $MTEN $IVP $RIME $IBRX $JTAI $GSIT $XBI $RARE $VKTX $ADTX $HIND https://t.co/V5pc5SZLps $GLMD loaded up last couple of days: Yahoo Finance Financial Highlights of $Glmd Total Cash $19M Book Value Per Share $3.49 $KULR $SAFX $SRXH $SCNX $MTEN $IVP"  
[X Link](https://x.com/ej23ny/status/2020880655358300190) [@ej23ny](/creator/x/ej23ny) 2026-02-09T15:21Z [----] followers, [---] engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing